Health Canada
- Status: approved
🇨🇦 DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE in Canada
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE (DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE) regulatory status in Canada.
Marketing authorisation
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in Canada
Frequently asked questions
Is DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE in Canada?
AUROBINDO PHARMA USA is the originator. The local marketing authorisation holder may differ — check the official source linked above.